Clinical Trial Details

EORTC-55985

Back to Clinical Trials Database

PHASE II CLINICAL TRIAL ON TAXOL AS SINGLE AGENT IN LOCALLY ADVANCED AND/OR METASTATIC OR RECURRENT VULVA CANCER NOT AMENABLE FOR SURGERY AND/OR RADIOTHERAPY - EORTC trial 55985

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 07-Feb-2001
Date Step1 close: 18-Feb-2005
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 29
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/NCT00014599
NCT number NCT00014599